Psychedelics Archives - Page 31 of 68

2 minute read

Next-Gen Israeli Psychedelics Company Gears Up For Trial Targeting Alcohol Addiction

May 3, 3:04 PM

Alcohol Use Disorder (AUD) is one of the top-targeted health issues by biopharma companies. In the case of Clearmind Medicine (NASDAQ: CMND), the Israel-based company is going at it through its MEAI-based proprietary drug candidate, CMND-100.

CMND

3 minute read

Zappy Zapolin Talks Psychedelics And Breakthrough Delivery Methods: The Future Has Arrived And It’s Awesome

By Maureen Meehan

May 3, 9:23 AM

Mike ‘Zappy’ Zapolin, Chief Visionary Officer of Psycheceutical Bioscience, Inc (OTCPK: BWVI), whom we'll call Zappy, shared his vision for the future of psychedelics at the recent Benzinga Psychedelics Capital Conference in Miami.

BWVI

2 minute read

Psychedelics Company Confirms Shares Spinout, Another Fails To File Financials & Gets CTO Issue

By Lara Goldstein

May 3, 7:49 AM

Blackhawk and MindBio Complete Plan Of Arrangement, Shares Spinout

IWINF

1 minute read

Parkinson’s Patients May Benefit From Ketamine, PharmaTher Applies For FDA Fast Track

By Nicolas Jose Rodriguez

May 3, 7:08 AM

Specialty pharmaceutical company PharmaTher Holdings (OTCQB: PHRRF) has submitted a Fast Track Application to the Food and D

PHRRF

3 minute read

EXCLUSIVE: AMA Moves Toward Psychedelic Therapy Reimbursement, ‘Filing A Gap’ In Regulations

By Lara Goldstein

May 2, 7:00 AM

The American Medical Association (AMA) is expected to issue the first code for psychedelic therapy reimbursement, following Tuesday's approval of a joint application submitted by MAPS PBC and COMPASS Pathways (NASDAQ: CMPS).

CMPS

3 minute read

Psyched: Oregon And Colorado Regulations, MindMed CEO Discusses LSD Therapy, Mia Khalifa Enters Market & More

By Lara Goldstein

May 1, 7:06 PM

Oregon Pioneers Legal Psilocybin Therapy, But This Type Of License Has Yet To Be Issued

AWKNF

6 minute read

The Role Of Drugs In Batman’s World: Unmasking The Dark Side Of Gotham

By El Planteo

April 30, 12:38 PM

This article written by Santiago Alonso was originally published in El Planteo and appears here with permission.

WBD

2 minute read

Awakn’s Q4 2023 And Annual Financials, +500% YoY Revenue Increase Following Network Expansion

By Lara Goldstein

April 28, 12:57 PM

The UK-based psychedelics biotech company Awakn Life Sciences Corp. (OTCQB: AWKNF) reported on its financial results and business highlights for the three and twelve months ended Jan. 31, 2023.

AWKNF

2 minute read

Tryp Therapeutics Secures $1.6M Via Oversubscribed Private Placement

By Vuk Zdinjak

April 27, 8:16 AM

Tryp Therapeutics Inc. (OTCQB: TRYPF) (CSE:TRYP), a clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active metabolite of psilocybin) for diseases with high unmet medical needs, has closed its private placement of sec

CSE:TRYP

2 minute read

This Firm Bets On Non-Hallucinogenic Psychedelics, Files Claims For International IP Protection

By Lara Goldstein

April 26, 2:52 PM

Numerous biopharma companies are working on enhancing first-generation or “classical” psychedelics. They're tuning down the side effects, and protecting their findings along the way.

MSSTF